New findings suggest that Phelan-McDermid Syndrome is nearly twice as common as previously thought — and the reason comes down to a critical flaw in how genetic testing has long been conducted. Read on to learn more about how accurate prevalence data is the key to meaningful improvements in care, research, and therapy development.